Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GATAD2A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GATAD2A is a transcriptional repressor and component of the NuRD (Nucleosome Remodeling Deacetylase) complex. It is implicated in Parkinson's disease risk through GWAS and plays critical roles in chromatin remodeling, gene regulation, and neuronal survival.
No AI portrait yet
| Gene Symbol | GATAD2A |
| Full Name | GATA Zinc Finger Domain Containing 2A |
| Aliases | Nucleosome Remodeling Deacetylase |
| Chromosome | 19p13.2 |
| Function | GATAD2A plays critical roles in gene regulation through its involvement in the NuRD complex: |
| Primary Expression | human tissues: - Brain: High expression in cortex, hippocampus, [striatum](/brain- |
| Amino Acids | 593 aa |
| UniProt ID | Q9ULJ8 |
| NCBI Gene ID | 54898 |
| Ensembl ID | ENSG00000176165 |
| OMIM | 607336 |
| GeneCards | GATAD2A |
| Human Protein Atlas | GATAD2A |
| Histone deacetylation | HDAC1/2 remove acetyl groups, creating transcriptionally repressive chromatin |
| Nucleosome remodeling | CHD4 repositioning makes DNA less accessible to transcription factors |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
GATAD2A["GATAD2A"]
neurodegeneration["neurodegeneration"]
GATAD2A -->|"implicated in"| neurodegeneration
Parkinson_S_Disease{"Parkinson'S Disease"}
GATAD2A -->|"implicated in"| Parkinson_S_Disease
Neuronal_Survival(["Neuronal Survival"])
GATAD2A -->|"promotes"| Neuronal_Survival
Transcription(["Transcription"])
GATAD2A -->|"regulates"| Transcription
style GATAD2A fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#fff
style Parkinson_S_Disease fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350
style Transcription fill:#2a2a1a,stroke:#ffd54f,stroke-width:1px,color:#ffd54f
style Neuronal_Survival fill:#2a2a1a,stroke:#ffd54f,stroke-width:1px,color:#ffd54f| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GATAD2A in their description or question text
No additional research found